FDA wants ADHD drugs to carry patient advisory guides on risks
Thu, 22 Feb 2007 10:26 AM EST
... Manufacturers of drugs used in the treatment of attention deficit hyperactivity disorder (ADHD) have been directed by health officials to introduce additional guidance to patients on the risks of cardiovascular and psychiatric diseases possible through the use of these drugs. ...
Related Topics
- Patient Issues
- Personal Medical Records
- Dietary Guidelines
- ADHD
- Bioethics
- Medication
- Amniocentesis
- Tacrolimus ointment
- Mammography
- Guanfacine
- Travel Health
- Anticancer Drugs
- Date Rape Drugs
- Disease-modifying anti-rheumatoid drugs
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Carcinogens
- Attention Deficit Hyperactivity Disorder (ADHD)
- Attention Deficit Hyperactivity (ADHD), Adult
- Pimecrolimus Cream 1%
- Erectile Dysfunction

Not Signed In -


